<?xml version="1.0" encoding="UTF-8"?>
<p>Several AT1R antagonists have already been on the market as antihypertensive drugs for many years, are inexpensive, widely used, and have virtually no side effects, which make them the ideal treatment option for SARS-CoV-2 infection. We are not the only ones suggesting this hypothesis; several other researchers have come to the same conclusion.
 <xref rid="pvaa053-B37" ref-type="bibr">
  <sup>37â€“39</sup>
 </xref>
</p>
